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K
enneth Yamada’s interest in cell 
movements began as a PhD stu-
dent with Norman Wessells at 
Stanford University in the late 1960s, 
where he studied the contribution of actin 
fi  laments and microtubules to axon growth 
(1). As a postdoc with James Weston at 
the University of Oregon and then with 
Ira Pastan at the National Cancer Institute 
in Bethesda, MD, Yamada characterized 
fi  bronectin (2)—a key component of the 
extracellular matrix with roles in cell 
adhesion, migration, and morphogenesis.
Yamada has maintained an interest in 
all three of these fi  elds during his 30 years 
as an investigator at the National Institutes 
of Health. In that time, he’s taken his re-
search into new dimensions—studying ad-
hesion and migration in 3D (3) and, more 
recently, 1D models (4). He has also used 
different systems to investigate 
branching morphogenesis (5), a 
developmental process that can 
be recapitulated in vitro with 
isolated salivary gland cells 
(6). When asked to name his 
favorite publication, Yamada 
demurs, saying that it would be 
like having to choose his favor-
ite child. That sense of fairness 
is refl  ected in Yamada’s service 
on the NIH’s scientifi  c conduct and ethics 
committee, where he educates researchers 
on the dangers of image manipulation (7).
In a recent interview, Yamada ex-
plained how curiosity and luck have 
guided him through a long and successful 
research career.
EARLY EXPLORATIONS
What were your earliest experiences 
in science? 
My father was a research technician who 
became a physician. We actually kept my 
father’s lab’s guinea pigs in a large bank of 
cages at our house. Those were the days 
before animal care committees, so those lab 
animals were my fi  rst exposure to science.
But I’ve always been very curious—
I tend to plunge immediately into a topic 
because it intrigues me, without fi  guring out 
an endpoint. For example, when I was a pre-
schooler I wanted to understand how door 
locks worked. I carefully took apart our 
house locks, but then couldn’t reassemble 
them, to the disapproval of my parents!
What would you be if not a scientist?
Maybe I was born in the wrong century, 
but I think I should have been an explorer. 
I guess the equivalent now might be a 
wildlife photographer. I really like pho-
tography, so that might’ve been it.
You did an MD-PhD. Did you intend to 
practice medicine at one point?
It was a very diffi  cult choice between med-
icine and basic research. I did all my grad-
uate work fi  rst, and then I went to the clin-
ics. It was like a forced sabbatical for three 
years and I discovered that I 
really missed designing ex-
periments and discovering 
new things. I think I actually 
had withdrawal symptoms. 
So that’s when I fi  gured out 
that I had to do basic re-
search. But I don’t regret the 
medical training at all. It 
gives you a broad exposure 
to all kinds of different 
knowledge, a viewpoint relevant to human 
health, and it teaches you the importance 
of time management.
How did you end up working with 
Norman Wessells?
I’d worked with him as an undergrad, 
and I really loved the way he mentored. 
It was a sink-or-swim approach in which 
he gave an exceptional level of autonomy 
to his students, and yet was always avail-
able for discussion.
I could make up my own experiments, 
or change projects completely. It was a great 
time because we were trying to understand 
roles of actin microfi  laments—using  the 
wonder drug at that time, cytochalasin—
and comparing them with microtubules in 
axon extension and cell migration.
Were there times when you thought you 
might sink rather than swim?
Not really. Nowadays, people panic sooner, 
but things were different then. We had 
time to do whatever we thought was inter-
esting, without worrying about a career. 
We could do what we loved to do and 
hope it would all work out in the end.
DRAFTED INTO SERVICE
After completing your MD, you went to 
Oregon for a postdoc with James Weston.
That was actually one of the luckiest acci-
dents of my life. During the Vietnam War, 
everyone with medical training was draft-
ed. I was strongly opposed to the war, and 
so, like a number of other now-senior 
researchers, I was able to fulfi  ll my mili-
tary obligation by serving in the US Public 
Health Service at the NIH. But I actually 
miscalculated and missed the application 
deadline, so I had to fi  ll in one year.
I hooked up with Weston because I 
thought the fi  eld of cell surface biology was 
going to be important. He had been working 
on a factor that suppressed contact inhibi-
tion of migration. I joined his lab to purify 
and characterize that mystery protein.
I set up a reliable bioassay, extracting 
material with low concentrations of urea 
from fi   broblasts, but I kept running into 
this major contaminant that actually looked 
quite pure on SDS gels. It ran at about 220 
kD. I decided that I might as well study a 
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purifi  ed protein that nature had given me as 
a gift. We characterized it, and wrote PNAS 
and Cell papers on that contaminant protein 
that turned out to be fi  bronectin.
Did you think that you’d still be working 
on the same protein 30 years later?
I thought that it would open up interesting 
new areas, though at the time I thought 
fi  bronectin would be involved in growth 
regulation rather than cell adhesion. It’s 
remarkable though—when we have 
meetings, we have many of the original 
people in the fi  eld who are still working 
on fi  bronectin or related molecules. It’s a 
protein that’s been very good to a lot of us.
Young researchers should always try 
to study a new protein if they can, because 
there are going to be really interesting sur-
prises. It gives you tremendous opportu-
nities and it’s a lot of fun. Of course, it 
all depends on having a good mentor. I’ve 
been lucky in that sense too: I had another 
mentor at the NIH, Ira Pastan, who gave me 
a lot of creative freedom, even as a postdoc.
Do you take a sink-or-swim approach 
in your own mentoring?
The ultimate goal is still to have my postdocs 
become completely independent. They’re 
responsible for making the key decisions, 
but I’m always happy to give lots of advice.
Also, I feel strongly that postdocs 
should be allowed to take their project 
with them, to start their own lab. And that 
actually has a positive effect on our own 
research, because it forces us to go in new 
research directions. We stay in the same 
general area of extracellular matrix, cell 
dynamics, and so forth, but we don’t take 
a linear, focused approach to research, 
which actually fi  ts with my personal pref-
erences, too.
MIGRATION AND MORPHOGENESIS
As a result, you use many different 
model systems in your research. When 
did it become clear to you that 2D 
models of migration weren’t sufﬁ  cient?
We were interested in cell adhesion and 
migration in fi  broblasts, and had started 
to worry that what we were looking at 
wasn’t entirely correct, so we developed 
3D models. I’ve published a lot in 2D, 
and I think we actually missed quite a bit. 
However, it’s also clear that differ-
ent extracellular matrices have dif-
ferent properties. So you can’t just 
say, “I’m working in 3D.” You also 
have to defi  ne whether it matches 
your physiological model.
Recently, we published a paper 
using micropatterning to study 1D 
migration, which seems to mimic 
3D migration closely. When Andrew 
Doyle was doing those studies in 
our lab, I would say, “We’ve got to 
fi  nd something where 2D is closer to 
3D than 1D, otherwise nobody will 
believe us.” We don’t want to appear as 
if we’re attacking people who use regular 
2D tissue culture. But so far, we haven’t 
found anything in 2D studies closer to 3D 
than 1D. It’s pretty surprising that there 
are so many differences in 2D.
How do these different models of 
migration compare?
First of all, overall cell morphology is 
uniaxial in 1D and 3D. Whereas in 2D, 
fi   broblasts have lamellae going off in 
multiple directions. The migration rate is 
signifi  cantly faster in 1D—cells seem to 
love straight lines. It’s a dogma in the 
cell adhesion fi  eld that there’s an optimal 
concentration for the adhesive surface: if 
you have too little adhesion, the cells 
have poor traction; if there’s a lot, then 
the cells form strong attachments and 
won’t migrate fast. But in 3D you have 
almost pure protein and proteoglycan 
fi  bers. So that’s a very high local concen-
tration. It turns out that in 1D you can 
have extremely high levels and the cells 
still migrate fast. So that’s another differ-
ence compared to 2D, which does show 
the classic biphasic behavior.
There are other differences, too. 
Myosin II contractility doesn’t seem to be 
essential for 2D migration, but you get 
slower migration in 3D and 1D if you 
inhibit myosin II. And the centrosome 
leads the way for cells migrating in 2D, 
whereas in 3D and 1D, the centrosome’s 
at the rear. We’re now trying to identify 
differences in the signaling systems be-
tween 2D and 3D—we’re going to look 
at Rho family GTPase functions next. The 
overall question is whether there really are 
fundamental differences in the mechanism 
and regulation of migration in 2D versus 
3D or 1D. We don’t really know.
You’re also interested in salivary gland 
branching morphogenesis. What is it 
that fascinates you about the process?
I think it’s the dynamics—I’m a very visual 
person, so this dramatic remodeling is 
really intriguing. What kind of physical 
and signaling cues allow cells to assemble 
a complete and functional organ? Remark-
ably, it turns out that fibronectin is re-
quired for branching morphogenesis, so 
things have come full circle. We can now 
reconstitute the process with dissociated 
salivary epithelial cells. They can reas-
semble and self-organize into a tissue. It’s 
just astonishing when you watch how 
incredibly motile these cells are.
We’re learning that there’s no pre-
ordained map of where branches should 
occur, and cells seem to readjust very 
quickly. So in the reconstituted system, 
a duct cell can become a bud cell. And 
we’re helping to construct a develop-
mental gene atlas of salivary gland de-
velopment using laser micro-dissection 
that will look at differences in gene 
expression in all the different cell types. 
We hope to identify the genes and mech-
anisms involved in morphogenesis, but it 
will be complicated.
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One of Yamada’s favorite photos, taken in the Masai 
Mara, Kenya.